Following a positive CPI update yesterday, markets bounced, but the question remains—was it enough?
[]Equal-Weighted S&P 500: Moved above the 50 EMA briefly before closing below it, showing an Unbalanced Volume Divergence. This raises caution about a potential reversal or continued range-bound behavior. []Russell 2000: Slightly stronger than the S&P 500, staying above the 50 EMA and neckline of its chop zone.
VIX and Broader Market Indicators:
[]VIX: Currently at 15.94, hovering in the lower range but not yet making a new low. []Growth stocks have improved, with the S&P 500 growth segment above its 20-day average at 59.80. []Industrials: Strong at 74, nearing reversal zones. []Energy stocks: Remain at the higher end of their 20-day average, but typically, this zone precedes declines.
Regional Updates:
[]U.S. Futures: Both the S&P 500 and Nasdaq 100 show green pre-market numbers but face resistance at key levels. []Europe: Markets have shown strength but remain near resistance levels where prior declines have occurred.
Asia: Nothing notable; markets remain flat.
Sector and Commodity Highlights:
[]Taiwanese Semiconductor Manufacturing (TSMC): Reported strong earnings, with a revenue surprise. []Crypto markets: Under mild pressure but holding within ranges.
Commodities: Silver, copper, and gold are trying to push higher but are still within established ranges.
Screener Results:
[]20% Gainers: 22 symbols, dominated by health technology, though mostly small caps (largest market cap: $13 billion). []8% Weekly Gainers:
[]227 symbols, with a mixed bag of sectors including energy minerals, finance, health technology, and consumer durables. []Notable names include Mazda, Nintendo, and a few energy stocks.
[]8% Weekly Losers:
[]147 symbols, also a mixed bag with no clear sector dominance.
Neutral-to-bearish stance today, with a cautious outlook. Watching for signs of a reversal or clear breakouts before committing to larger positions. Leaning short in this chop zone, but the market remains undecided.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.